Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/3/2019 |
| Start Date: | February 26, 2018 |
| End Date: | November 17, 2018 |
A BIOEQUIVALENCE STUDY OF THE GENERIC BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION COMPARED TO REFERENCE LISTED DRUG AZOPT® (BRINZOLAMIDE) OPHTHALMIC SUSPENSION 1% IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of
topical brinzolamide compared with AzoptTM
topical brinzolamide compared with AzoptTM
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of
topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic
suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.
topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic
suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.
Inclusion Criteria:
- Male and females 18 years of age or older,
- diagnosed with primary open-angle glaucoma or ocular hypertension.
Exclusion Criteria:
- Patients with any form of glaucoma (such as secondary, congenital, juvenile or normal
tension glaucoma, angle closure glaucoma) in either eye other than primary open-angle
glaucoma,
- ocular hypertension.
We found this trial at
1
site
Click here to add this to my saved trials
